Cormedix share price logo

Cormedix

NASDAQ: CRMD

Small Cap

$7.72

-0.07

(-0.90%)

as on

Cormedix Stock Performance

as on September 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $7.62
    $7.78
    downward going graph

    1.30%

    Downside

    0.78%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.13
    $13.02
    downward going graph

    20.66%

    Downside

    68.65%

    Upside

    downward going graph

Cormedix share price movements today

Previous Close
$7.79
Open
$7.67
Volume
608.9K
Market Cap
$609.5M
Day's Low - High
$7.62 - $7.78
52 Week Low - High
$6.13 - $13.02

Cormedix Historical Returns

1 Month Return
-8.57 %
3 Month Return
-10.15 %
1 Year Return
-30.45 %
3 Year Return
+ 105.54 %
5 Year Return
+ 66.81 %

Cormedix Stock Fundamentals & Key Indicators

Check Cormedix market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$609.5M

EPS (TTM)

2.41

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.07%

PE Ratio (TTM)

3.23

Industry PE ratio

-6.87

PEG Ratio

0.015467759590662631

EBITDA

249.6M

Revenue (TTM)

462.2M

Profit Margin

82.78%

Return On Equity TTM

44.64%

Cormedix Stock Valuation

Track how Cormedix P/E has moved over time to understand its valuation trends.

Cormedix in the last 5 years

  • Overview

  • Trends

Lowest (-26.60x)

December 31, 2024

Industry (-6.87x)

December 31, 2025

Today (5.17x)

December 31, 2025

Highest (5.17x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 5.17x

Cormedix vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cormedix with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$609.5M66.81%3.2382.78%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Cormedix Stock including INR - Dollar returns

The Cormedix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cormedix investment value today

Current value as on today

₹74,843

Returns

-₹25,157

(-25.16%)

Returns from Cormedix Stock

-₹31,071 (-31.07%)

Dollar Impact

₹5,915 (+5.91%)

Analyst Recommendation on Cormedix Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Cormedix. Average target price of $15.4

Cormedix Share Price Target

Get share price movements and forecasts by analysts on Cormedix.

What analysts predicted

49.87%UPSIDE

Target Price

$15.4

Current Price

$7.72

Analyzed by

3 Analysts

Target

$15.40

Cormedix target price $15.4, a slight upside of 49.87% compared to current price of $7.72. According to 3 analysts rating.

Indian Investors' Interest in Cormedix Stock

Search interest for Cormedix Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-41% versus previous 30 day period

Cormedix Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
0
11
31
39
39
104
128
127
101
Gross Profit
0
0
10
30
37
37
93
107
105
77
Operating Income
-16
-15
-3
12
20
19
51
59
63
42
EBITDA
-15
-14
-2
13
20
20
57
68
66
57
Interest Expense
0
0
0
0
0
0
0
1
-
-
Depreciation
0
0
0
0
0
0
3
10
10
10
Income Before Tax
-15
-14
-2
13
20
20
52
56
55
38
Income Tax Expense
-1
-
-
-
-
0
-55
42
17
12
Net Income
-14
-14
-2
13
20
19
108
14
38
25
Net Profit Margin
0.00%
36.75%
94.01%
96.23%
95.91%
95.31%
89.26%
83.43%
82.50%
75.66%

Cormedix Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
0
0
-
43
311
Gross Profit
0
0
0
0
0
0
0
40
275
Operating Income
-32
-26
-21
-27
-29
-30
-48
-22
150
EBITDA
-32
-26
-20
-27
-29
-30
-46
-18
167
Interest Expense
0
0
0
0
0
0
0
0
2
Depreciation
0
0
0
0
0
0
0
0
14
Income Before Tax
-33
-26
-11
-27
-29
-30
-46
-19
150
Income Tax Expense
0
0
5
-5
-1
0
-
-1
-13
Net Income
-33
-26
-16
-22
-28
-29
-46
-17
163
Net Profit Margin
65.09%
7.68%
-31.76%
14.37%
22.00%
94.29%
0.00%
92.66%
88.46%

Cormedix Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-14
-14
-2
13
20
19
108
14
38
-38
Operating Cash Flow
-17
-14
-13
-5
19
29
30
94
42
86
Investing Cash Flow
8
6
6
0
0
-20
-291
3
2
0
Financing Cash Flow
0
1
14
11
6
83
150
-1
-12
-7
Change in Cash
-8
-6
6
5
25
93
-109
96
33
78

Cormedix Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-33
-26
-16
-22
-28
-29
-46
-17
163
Operating Cash Flow
-28
-23
-15
-21
-21
-24
-38
-50
175
Investing Cash Flow
10
1
-12
7
-9
-3
-17
21
-308
Financing Cash Flow
20
29
25
40
41
17
55
26
238
Change in Cash
2
7
-1
25
11
-10
0
-3
105

Mutual Funds that own Cormedix Stock

Check out the Mutual Funds with significant holdings in Cormedix.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.921809%
3056828
ROYCE FUND
1.521278%
1185750
Fidelity Salem Street Trust
1.031287%
803830
Fidelity Concord Street Trust
0.947883%
738821
VANGUARD SCOTTSDALE FUNDS
0.566401%
441478

Global Institutional Holdings in Cormedix

Funds
Holdings
Vanguard
4.87%
iShares
4.58%
Chuck Royce
2.79%
Avantis
2.65%
James E. Flynn
1.42%

Cormedix News & Key Events

    Insights on Cormedix

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, CRMD has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 3 years, CRMD stock has moved up by 112.7%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 541.4%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, 38.60M → 25.98M (in $), with an average decrease of 32.7% per quarter

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 3 quarters, 128.61M → 101.93M (in $), with an average decrease of 10.5% per quarter

    About Cormedix

    CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
    OrganisationCormedix
    Headquarters389 Interpace Pkwy, Parsippany, NJ, United States, 07054
    IndustryBiotechnology
    CEOMr. Joseph Todisco MBA
    E-voting on sharesClick here to vote

    Key Management of Cormedix

    Name

    Title

    Mr. Jared L. Crandon Pharm.D.

    Executive Director of Clinical Portfolio Management

    Mr. Joseph Todisco MBA

    CEO & Chairman of the Board of Directors

    Ms. Elizabeth Masson-Hurlburt B.A.

    Executive VP and Chief Operating & Commercial Officer

    Ms. Kaufman Beth Zelnick Esq.

    EVP, Chief Legal and Compliance Officer & Corporate Secretary

    Ms. Beth Steinbrenner

    SVP & Chief Human Resource Officer

    Dr. Matthew T. David M.D.

    EVP & Chief Business Officer

    Donna Ucci

    Senior VP & Head of Global Quality

    Ms. Susan Blum

    EVP & Chief Financial Officer

    Dr. Tushar Mukherjee

    Senior VP & Head of Technical Operations

    Dr. Peter Sullivan BCOP, Pharm.D.

    Senior Vice President of Market Access

    FAQs

    What is Cormedix share price today?

    Cormedix share price today is $7.72 as on at the close of the market. Cormedix share today touched a day high of $7.78 and a low of $7.62.

    What is the 52 week high and 52 week low for Cormedix share?

    Cormedix share touched a 52 week high of $13.02 on and a 52 week low of $6.13 on . Cormedix stock price today i.e. is closed at $7.72,which is 40.71% down from its 52 week high and 26.04% up from its 52 week low.

    What is Cormedix's market capitalisation today?

    Cormedix market capitalisation is $0.00T as on .

    How to invest in Cormedix Stock (CRMD) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Cormedix on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cormedix Shares that will get you 0.1943 shares as per Cormedix share price of $7.72 per share as on September 19, 2026 at 8:45 am IST.

    What is the minimum amount required to buy Cormedix Stock (CRMD) from India?

    Indian investors can start investing in Cormedix (CRMD) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹958.80 in Cormedix stock (as per the Rupee-Dollar exchange rate as on ). Based on Cormedix share’s latest price of $7.72 as on September 19, 2026 at 8:45 am IST, you will get 1.2953 shares of Cormedix. Learn more about fractional shares .

    What are the returns that Cormedix has given to Indian investors in the last 5 years?

    Cormedix stock has given 66.81% share price returns and 30.25% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?